PCM TRIALS - Quality Mobile Research

We’re thrilled to be attending #SCOPE2025 alongside EmVenio Research, February 3-6th! 🤝 Connect with Jeff Huntsman, Jonathan Ernst, Brandon Wall, MHA, Jamal Shuja, or Ronald Ramos to schedule a meeting, or stop by booth #1430 to learn more about our community-based research services. 🎤 Join us for the following speaker session on Tuesday, February 4th at 1:05 PM • “The Road Less Traveled: Bridging the Research Gap in Rural and Tribal Communities” Presented by Jonathan Ernst, Vice President, In-Home Solutions, PCM Trials. This session will explore real-word strategies for overcoming logistical barriers in research in rural and underrepresented communities. ⭐ Enjoy drink, appetizers, and live music while exploring our mobile research site at an evening reception on the terrace of the Rosen Shingle Creek Hotel. • Tuesday, February 4th, 7:15-8:20 PM • RSVP here: https://hubs.ly/Q031Pfxt0 🩺 Stop by booths #1428/#1430 for a free blood pressure and heart rate check from one of our attending providers. We can’t wait to connect with you at SCOPE 2025 – see you in Orlando!🌴 #ClinicalTrials #CommunityResearch #AccessForAll #HealthEquity

In a 2024 survey, 91% of industry professionals reported increased patient retention as a key benefit of mobile visits in clinical trials. Community-based research activities, such as mobile visits, reduce the burden on participants, improve protocol compliance, and expand trial access for historically underrepresented populations. Notably, trials utilizing mobile visits have demonstrated expedited enrollment periods – by an average of 6.18 months – compared to traditional models. Read the full article to learn how mobile visits are improving trial outcomes for both patients and sponsors: https://hubs.ly/Q031mwRk0 #ClinicalResearch #AccessForAll #PatientRetention #CommunityResearch

As 2024 comes to a close, we’re reflecting on a transformative year at PCM Trials – one defined by growth, integration, and a steadfast focus on improving patient access to clinical research. This year, we achieved significant milestones: the acquisitions of Clinical Trial Service B.V. and EmVenio Research expanded our global footprint, strengthened our capabilities, and embedded us even more deeply in the communities we serve. As a result, we now have the ability to reach more patients than ever before, breaking down barriers to participation in clinical research for historically underrepresented populations. In 2024, we unified our teams around a shared vision, streamlined our business development operations, and successfully integrated our site-based and mobile research services into one seamless, community-based research model. In our latest blog, Jeff Huntsman, Chief Commercial Officer at PCM Trials, reflects on the successes of 2024 and shares bold priorities for 2025. If you’re a sponsor or CRO, this is your invitation to see how PCM Trials is preparing to meet the industry’s most pressing challenges head-on in the new year. Read the full blog here: https://hubs.ly/Q030VPSM0 #ClinicalResearch #AccessForAll #EndOfYearReflection #NewYear

❄️Wishing you a happy holiday season from PCM Trials!❄️ As the year comes to a close, we’re reflecting on the meaningful moments that shaped 2024. This year, we’ve experienced tremendous growth, allowing us to reach more patients and communities than ever before. From empowering participants with community-based research to partnering with innovative sponsors and CROs, we’ve worked together to bring research to life – whenever and wherever life happens. We’re deeply thankful for the dedication of our clinicians, the trust of our partners, and the invaluable contributions of every participant who joined us on this journey. Together, we’re reimagining the clinical trial experience and delivering results that truly matter. Here’s to a new year filled with innovation, collaboration, and continued progress! #HappyHolidays #ClinicalResearch #CommunityResearch

Social determinants of health (SDOH) like housing, transportation, and social support play a powerful role in clinical trial participation. Yet, they’re often overlooked. Discover why addressing SDOH isn’t just important—it’s essential for achieving diversity, improving patient retention, and ensuring real-world relevance in study results. Ready to unlock the potential of inclusive research? Dive into this insightful article: https://hubs.ly/Q02_WvfD0 #ClinicalTrials #HealthEquity #SDOH #DiversityInResearch #PatientRecruitment #EmVenioImpact

The data is clear: underrepresented populations still face major barriers to clinical trial participation. From 2017-2024, over 70% of US-based trial participants identified as white, leaving underrepresented groups largely excluded. At the same time, mentions of ‘diversity in clinical trials’ in sponsor filings have surged by 300% , signaling an urgent commitment to change. Community-based research models reduce logistical and geographical barriers, broadening trial accessibility for traditionally underrepresented populations. By meeting patients in their homes and communities, we help sponsors meet FDA diversity benchmarks and ensure equitable, representative research. Learn more about how community-based research models extend the reach of clinical trials to facilitate greater participation for underrepresented groups in our latest article: https://lnkd.in/gtsBzZ3B #AccessForAll #EquityInResearch #Diversity #ClinicalTrialDiversity  

In our most recent webinar, Stephanie Hitchcock and Kristofer Booth, MBA explored recent FDA guidance on diversity in clinical trials, emphasizing the critical role of diversity action plans in improving enrollment and retention of underrepresented populations. The conversation focused on how to make highly inclusive trials a reality through actionable, patient-centric strategies, including the use of mobile visits and community-based research sites. These approaches help remove barriers to participation to expand the reach of clinical trials and ensure that research reflects the diversity needed to drive better health outcomes for all. Interested in learning more? Watch the full webinar below, or read some of the key takeaways here: https://lnkd.in/g_t8_vbC #AccessForAll #InclusiveResearch #CommunityResearch #DiversityInResearch  

November is National Alzheimer's Awareness Month! With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s - and projections reaching nearly 13 million by 2050 - addressing the unique needs of this population is critical. Alzheimer’s patients often face significant barriers to trial participation, from mobility challenges to the need for caregiver support, making accessible and inclusive research solutions essential. At PCM Trials, we are proud of our deep history of advancing Alzheimer’s research through our community-based research model. By delivering research services directly to participant’s homes and enabling caregiver participation, we’re removing barriers and improving access for those impacted by Alzheimer's. Learn how mobile visits and community research support greater trial accessibility for aging populations here: https://lnkd.in/dBZtWgNh Join us in raising awareness by sharing how we can better support Alzheimer’s patients and caregivers! #AlzheimersAwareness #CommunityResearch #AccessForAll #AlzheimersAwarenessMonth

After months of hard work, we’re thrilled to debut our public television feature created in partnership with Viewpoint Project with Dennis Quaid. Our segment begins airing nationally this week, and you can watch the episode below! 📺 In this educational docuseries, we’re showcasing how our community-based mobile visits and clinical research sites are revolutionizing clinical trials by making them more accessible, increasing participant recruitment and retention rates, and promoting diversity. As the largest independent community site network and the most experienced provider of local clinical trial access globally, PCM Trials and EmVenio Research (a PCM Trials company) are delivering research services to underrepresented participants wherever they are - in their homes, workplaces, and communities. Watch the episode here: https://lnkd.in/gk3vsrMk #AccessForAll #CommunityResearch #HealthcareInnovation

In an interview at #DIA2024 earlier this year, Jonathan Ernst, Vice President of In-Home Solutions at PCM Trials, shared how we at PCM Trials and EmVenio Research are working to bridge critical gaps in clinical trial access to create a seamless participant journey. From early community outreach to the final visit, we’re dedicated to supporting participants and sponsors throughout the entire study process. By combining mobile visits and community-based elements, we are extending the reach of clinical research with a personalized approach. Learn more about our commitment to participant optionality and creating a truly accommodating trial experience here: https://lnkd.in/gsUjfCyP #AccessForAll #PatientCentricity #CommunityResearch #ClinicalResearch